v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ 17,516 $ (70,682)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
General and administrative expenses paid by related party 486,484
Interest income on investments held in the Trust Account (6,479,330)
Change in fair value of forward sale securities 4,608,560
Changes in operating assets and liabilities:    
Deferred offering costs 106,544 (106,544)
Prepaid expenses 201,667 2,740
Other assets (48,747)
Accrued expenses 1,150,290 94,586
Net cash provided by (used in) operating activities 42,984 (79,900)
Cash flows from investing activities:    
Maturity of available-for-sale debt securities held in Trust Account 244,925,000
Purchase of available-for-sale debt securities held in Trust Account (484,924,976)
Net cash used in investing activities (239,999,976)
Cash flows from financing activities:    
Proceeds received from initial public offering 240,000,000
Proceeds received from private placement 5,800,000
Offering costs paid (5,089,259)
Deferred offering costs paid by related party (213,079)
Proceeds from Notes payable – related party 477,207 79,900
Payment on Notes payable – related party (159,726)
Payment on Payable to related party (833,151)
Net cash provided by financing activities 239,981,992 79,900
Net change in Cash 25,000
Cash – beginning of the period
Cash – end of the period 25,000
Supplemental disclosure of non-cash activities:    
Deferred offering costs included in Accrued expenses $ 76,044